The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer.
暂无分享,去创建一个
Christian Siedschlag | Liesbeth Boersma | Judith van Loon | Maddalena Rossi | Angela van Baardwijk | Kenneth Gilhuijs | Joep Stroom | L. Boersma | K. Gilhuijs | J. Stroom | A. V. van Baardwijk | M. Rossi | J. V. van Loon | C. Siedschlag
[1] J C Stroom,et al. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.
[2] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[3] Kurt Baier,et al. Dose-response in stereotactic irradiation of lung tumors. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] M. Mehta,et al. Dose coverage beyond the gross tumor volume for various stereotactic body radiotherapy planning techniques reporting similar control rates for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[5] P. Lambin,et al. The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Lei Xing,et al. Stereotactic body radiation therapy in multiple organ sites. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Fowler,et al. The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation , 1976, Radiation research.
[8] L. Xing,et al. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. , 2005, Medical physics.
[9] James Bedford,et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] M. V. van Herk,et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[11] Liesbeth Boersma,et al. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. , 2012, International journal of radiation oncology, biology, physics.
[12] J C Rosenwald,et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. , 2000, International journal of radiation oncology, biology, physics.
[13] Marnix G Witte,et al. The effects of target size and tissue density on the minimum margin required for random errors. , 2004, Medical physics.
[14] L. Boersma,et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Joos V Lebesque,et al. Inclusion of geometric uncertainties in treatment plan evaluation. , 2002, International journal of radiation oncology, biology, physics.